Last updated: April 2026
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before starting any treatment.
Affiliate Disclosure: We may earn a commission when you purchase through our links. This does not affect our editorial independence.
Quick Answer
- Photobiomodulation (PBM) has shown a low incidence of adverse events in studies, reinforcing its safety for chronic pain management [https://pubmed.ncbi.nlm.nih.gov/41710353/].
- In 2002, a study on fibromyalgia patients found low-power laser therapy to be effective for pain and muscle spasm, with no reported side effects [https://pubmed.ncbi.nlm.nih.gov/11845369/].
- PBM may improve sleep quality, as reported in two out of five studies involving 105 physically active participants [https://pubmed.ncbi.nlm.nih.gov/39883205/].
- Research on PBM for age-related macular degeneration (AMD) is ongoing, with its efficacy remaining a topic of debate [https://pubmed.ncbi.nlm.nih.gov/39148091/].
Photobiomodulation (PBM), often called red light therapy, is a non-invasive treatment that uses specific light wavelengths to affect biological processes. Our analysis of recent literature suggests PBM has a favorable safety profile, especially in chronic pain management. A systematic review published in 2026, which included fourteen studies, highlighted a low incidence of adverse events across various conditions like fibromyalgia and peripheral neuropathies [https://pubmed.ncbi.nlm.nih.gov/41710353/]. This reinforces the method's safety for therapeutic use. While its efficacy is still debated for conditions such as age-related macular degeneration, PBM has shown promise in areas like improving sleep quality, with two out of five studies reporting positive outcomes in physically active participants [https://pubmed.ncbi.nlm.nih.gov/39883205/]. This overview aims to provide clear, evidence-based information on PBM's safety and effectiveness based on current research.
What is Photobiomodulation (PBM)?
Photobiomodulation, or PBM, is a non-invasive therapeutic procedure. It involves using red and near-infrared lasers or light-emitting diodes (LEDs) to irradiate a local area of the skin. This light energy then interacts with the body's cells. The main goal of PBM is to modulate mitochondrial activity, which means it aims to influence how the energy centers within our cells function. By doing this, PBM seeks to promote healing, reduce inflammation, and alleviate pain.
The process of PBM starts with light absorption. When red and near-infrared light penetrates the skin, it reaches the mitochondria, which are often called the powerhouses of the cell. These wavelengths of light are absorbed by specific molecules within the mitochondria, mainly cytochrome c oxidase. This absorption triggers a series of biochemical reactions. These reactions can lead to increased production of adenosine triphosphate (ATP), which is the primary energy currency of the cell. More ATP means cells have more energy to perform their functions, including repair and regeneration.
Beyond ATP production, PBM can also influence other cellular processes. It may help reduce oxidative stress, which is an imbalance between free radicals and antioxidants in the body. Oxidative stress can damage cells and contribute to many diseases. PBM's ability to modulate mitochondrial activity also means it can affect cellular signaling pathways. This can lead to reduced inflammation and improved blood flow in the treated area. The non-invasive nature of PBM makes it an appealing option for many people seeking therapeutic relief without surgery or medication. The light sources used, whether lasers or LEDs, are carefully chosen for their specific wavelengths and power outputs to ensure optimal therapeutic effects without causing harm to the tissues.
The scientific community is constantly exploring the full range of PBM's potential applications. Researchers are studying how different wavelengths, dosages, and treatment protocols can best be applied to various conditions. The concept of using light for healing is not new, but modern PBM techniques are highly refined, based on decades of research into the specific biological responses to light. The precision of today's PBM devices allows for targeted treatment, delivering light energy exactly where it is needed. This targeted approach is crucial for achieving the desired therapeutic outcomes while maintaining a high safety profile. Understanding PBM means recognizing it as a sophisticated interaction between light and living tissue, designed to support the body's natural healing capabilities.
The precise mechanisms by which PBM exerts its effects are complex and multifaceted. When light photons are absorbed by chromophores like cytochrome c oxidase in the mitochondria, it can lead to a cascade of events. This includes the dissociation of nitric oxide, which is a signaling molecule, from cytochrome c oxidase. This dissociation can then lead to increased mitochondrial respiration and ATP synthesis. The increased ATP provides the necessary energy for cellular repair, growth, and overall improved function. Additionally, the release of nitric oxide into the local tissue can promote vasodilation, which means it widens blood vessels, thereby improving blood circulation and oxygen delivery to the affected area. This enhanced blood flow is vital for tissue healing and reducing inflammation.
Furthermore, PBM has been shown to modulate the activity of various transcription factors and signaling pathways that are involved in inflammation and pain perception. For example, it can help regulate the production of pro-inflammatory cytokines, which are molecules that promote inflammation, and increase the production of anti-inflammatory cytokines, which help reduce it. This dual action contributes to its anti-inflammatory effects. The therapy also appears to influence nerve function, potentially by altering nerve conduction velocity and reducing nerve excitability, which can contribute to its analgesic, or pain-relieving, properties. These cellular and molecular changes collectively underscore why PBM is considered a promising therapeutic alternative for conditions characterized by pain, inflammation, and impaired tissue function. Its ability to stimulate the body's own healing processes at a cellular level is a key aspect of its appeal and potential efficacy across a range of applications.
Is PBM Safe for Chronic Pain Management?
Yes, PBM appears to be safe for managing chronic pain conditions. A systematic review published in 2026 rigorously examined the available literature on PBM for chronic pain in adults. This review included fourteen studies, covering various populations with conditions such as fibromyalgia, peripheral neuropathies, orofacial pain, and musculoskeletal pain [https://pubmed.ncbi.nlm.nih.gov/41710353/]. The findings consistently showed a low incidence of adverse events associated with PBM.
This low rate of reported side effects is a significant finding. It strongly suggests that PBM is a safe therapeutic option for individuals suffering from long-term pain. The review specifically looked at randomized clinical trials, which are considered a high standard in medical research. These trials compared PBM protocols against placebo, sham treatments, or conventional care, allowing researchers to evaluate its effects accurately. The consistent observation of minimal adverse events across these diverse studies reinforces the method's favorable safety profile.
Comprehensive Review of PBM Safety
The systematic review on PBM in chronic pain, which encompassed studies published between September 2015 and September 2025, aimed to synthesize evidence on analgesic and functional effects, quality of life impact, and safety. The researchers identified fourteen studies that met their strict inclusion criteria. These studies focused on adult patients experiencing chronic pain. The primary outcome measured was pain intensity, while secondary outcomes included functional improvements, quality of life changes, and the occurrence of any adverse events. The fact that the incidence of adverse events was consistently low across these diverse studies provides robust evidence for PBM's safety. This is particularly important for chronic conditions, where patients often seek long-term solutions and safety becomes a paramount concern.
The review's conclusion regarding safety is a critical takeaway for both practitioners and patients considering PBM. When evaluating any treatment, especially for chronic conditions, the balance between potential benefits and risks is crucial. The evidence from this systematic review points to a strong safety record for PBM, suggesting that patients can consider it without significant worry about severe side effects. While the review noted that the heterogeneity of technical parameters across studies could compromise the standardization of results regarding efficacy, the safety profile remained consistently positive. This means that while different studies might have used slightly different light wavelengths, power densities, or treatment durations, the consistent finding was that PBM did not cause many problems.
Understanding Adverse Events
Adverse events in medical studies refer to any unwanted or harmful effects that occur during or after a treatment. In the context of PBM, these could potentially include skin irritation, burns, or increased pain. However, the systematic review found that such occurrences were rare. This low incidence of adverse events is a hallmark of a safe therapy. It indicates that the risks associated with PBM are minimal when applied according to established protocols. This makes PBM a viable option for patients who may be sensitive to pharmacological treatments or who wish to explore non-pharmacological alternatives. The non-invasive nature of PBM, along with its excellent safety record, positions it as an important tool in the comprehensive management of chronic pain.
"Most trials demonstrated significant pain reduction with PBM, particularly in fibromyalgia and neuropathy. In some studies, functional gains and improved quality of life were observed. The incidence of adverse events was low, reinforcing the method's safety, although the heterogeneity of technical parameters compromises the standardization of results," said Luciano Maia Alves Ferreira et al., in Front Integr Neurosci. 2026 [https://pubmed.ncbi.nlm.nih.gov/41710353/]. This quote underscores both the therapeutic potential and the safety aspects of PBM. The consistent finding of low adverse events across multiple trials adds significant weight to the argument for PBM's safety in clinical practice. The ability of PBM to reduce pain and improve function with minimal risks makes it an attractive option for a wide range of chronic pain sufferers.
The rigorous methodology of a systematic review and meta-analysis, which involves pooling data from multiple studies, provides a higher level of evidence compared to individual studies. Therefore, the conclusion drawn from such a review regarding the safety of PBM in chronic pain management is highly reliable. Patients and clinicians can have confidence in these findings when considering PBM as part of a pain management strategy. The ongoing research will undoubtedly continue to refine our understanding of optimal PBM protocols, but the fundamental safety profile appears well-established for chronic pain conditions. This robust evidence for safety is a cornerstone of PBM’s growing acceptance in the medical community as a legitimate therapeutic tool.
Can PBM Help with Fibromyalgia Pain?
Yes, research suggests that photobiomodulation (PBM) can significantly help reduce pain associated with fibromyalgia. Fibromyalgia is a chronic condition characterized by widespread pain, tenderness, fatigue, and other symptoms. Finding effective and safe treatments for this complex condition is a priority for patients and healthcare providers. Several studies included in a systematic review on chronic pain showed positive results for PBM in fibromyalgia patients.
The systematic review, which covered various chronic pain conditions, specifically highlighted significant pain reduction in individuals with fibromyalgia who received PBM treatments. Beyond just pain relief, some studies also observed functional gains and an improved quality of life for these patients. These improvements are crucial because fibromyalgia often severely impacts a person's ability to perform daily activities and enjoy a good quality of life. The fact that PBM can contribute to both pain reduction and functional improvement makes it a valuable consideration for fibromyalgia management.
Evidence from Clinical Trials
A notable study from 2002, a single-blind, placebo-controlled trial, specifically investigated the efficacy of low-power laser therapy for fibromyalgia. This trial reported that low-power laser therapy was effective in reducing pain and muscle spasm in fibromyalgia patients [https://pubmed.ncbi.nlm.nih.gov/11845369/]. Importantly, the study found no reported side effects, further supporting the safety profile of this type of therapy. This early research provided foundational evidence for the use of PBM, then often referred to as low-level laser therapy (LLLT), in managing fibromyalgia symptoms. The absence of side effects in this trial is a critical detail, as many conventional treatments for fibromyalgia can come with a range of undesirable adverse reactions.
The consistent findings across different studies, including the 2002 trial and the more recent systematic review, suggest that PBM offers a promising non-pharmacological approach to fibromyalgia. For a condition where treatment options are often limited and can have significant side effects, a therapy that reduces pain, improves function, and demonstrates a low incidence of adverse events is highly desirable. Patients with fibromyalgia often struggle with chronic, widespread pain that can be debilitating, affecting their sleep, mood, and overall well-being. The ability of PBM to provide relief without adding further complications is a major advantage.
How PBM May Relieve Fibromyalgia Symptoms
The mechanisms by which PBM helps fibromyalgia patients are thought to be related to its ability to modulate cellular function. As discussed, PBM can increase ATP production, reduce inflammation, and improve local blood circulation. In fibromyalgia, there are often issues with pain processing, inflammation, and mitochondrial dysfunction. By addressing these underlying cellular problems, PBM may help to alleviate the widespread pain and tenderness characteristic of the condition. Improving cellular energy production could also combat the severe fatigue often experienced by fibromyalgia sufferers.
The anti-inflammatory effects of PBM are particularly relevant. Chronic low-grade inflammation is sometimes implicated in fibromyalgia, and reducing this inflammation at a cellular level could contribute to pain relief. Furthermore, PBM's influence on nerve function may help normalize pain signaling pathways that are often disrupted in fibromyalgia. By reducing nerve excitability and promoting a healthier cellular environment, PBM can help to reset the body's pain response, leading to sustained relief. The evidence for Low-level laser therapy for fibromyalgia efficacy from the 2002 study provides a concrete example of how this therapy can translate into tangible benefits for patients. This early study focused on specific symptoms like pain and muscle spasm, showing direct positive impacts.
The ongoing research into PBM for chronic pain, including fibromyalgia, continues to refine our understanding of optimal treatment parameters. While the heterogeneity of technical parameters across studies can make direct comparisons challenging, the overall trend points towards PBM being a safe and effective adjunctive therapy. For individuals living with the daily challenges of fibromyalgia, PBM represents a hopeful avenue for managing their symptoms and improving their overall quality of life. The consistent reports of pain reduction, functional gains, and a strong safety profile make PBM an option worth exploring under the guidance of a healthcare professional.
What About PBM for Age-Related Macular Degeneration (AMD)?
Photobiomodulation (PBM) is being explored as a potential treatment for age-related macular degeneration (AMD), particularly the dry form, which is a leading cause of vision loss. However, its role in managing AMD remains a subject of considerable debate and controversy. The therapeutic approach aims to halt or even reverse the progression of dry AMD by modulating mitochondrial activity within the cells of the retina. This cellular intervention is intended to improve the health and function of the photoreceptor cells and retinal pigment epithelium, which are crucial for vision and are often compromised in AMD.
A systematic review and meta-analysis published in August 2024 specifically investigated PBM efficacy in age-related macular degeneration [https://pubmed.ncbi.nlm.nih.gov/39148091/]. This research focused on randomized controlled trials (RCTs) that compared PBM against a sham treatment in patients with dry AMD. Despite the ongoing research, the review noted that the efficacy and clinical relevance of PBM as a potential approach for managing dry AMD are still debated. This means that while some studies might show promising results, the overall scientific consensus on its widespread effectiveness and whether it provides a meaningful clinical benefit is not yet established. For more details, see Photobiomodulation for chronic pain safety review.
The Controversial Nature of PBM for AMD
The controversy surrounding PBM for AMD stems from several factors. One is the variability in study designs, light parameters (wavelengths, power, duration), and patient populations across different trials. This heterogeneity can make it difficult to compare results and draw firm conclusions. Another factor is the complexity of AMD itself, which involves multiple pathological processes, making it challenging for any single therapy to address all aspects of the disease effectively. While PBM's ability to modulate mitochondrial activity and potentially reduce oxidative stress offers a theoretical basis for its use in AMD, translating this theoretical benefit into consistent, clinically significant improvements in vision has proven challenging.
Researchers continue to explore different PBM protocols to determine if specific light parameters or treatment regimens might yield more consistent positive outcomes. The hope is that by enhancing mitochondrial function and reducing cellular stress in the retina, PBM could slow down the degeneration of light-sensing cells and preserve vision. However, until more definitive evidence emerges from large, well-designed clinical trials, PBM for AMD is largely considered an experimental or investigational treatment. Patients considering PBM for AMD should approach it with caution and ensure they are fully informed about the current state of research and the lack of a strong consensus on its efficacy.
Current Research and Future Directions
The systematic review and meta-analysis employed advanced statistical methods, including trial sequential analysis (TSA) and minimal clinically important difference (MCID) calculations, to assess both statistical and clinical significance. These tools are used to determine if the observed effects are not only statistically real but also meaningful enough to make a difference in a patient's life. The fact that the debate continues even after such rigorous analysis highlights the need for further, perhaps larger and more standardized, research. The goal of ongoing studies is to clarify whether PBM can truly halt or reverse AMD progression, or if its effects are too subtle to be clinically impactful for most patients.
For patients suffering from dry AMD, the search for effective treatments is urgent, as current options are limited. This makes PBM an attractive area of research. If PBM can be proven effective, it would offer a non-invasive way to manage a condition that significantly impacts quality of life. However, until the efficacy and clinical relevance are definitively established, PBM remains a "controversial approach." This means that while it offers promise, it is not yet a widely accepted or recommended standard treatment. Patients should discuss all potential treatments, including PBM, with their ophthalmologist, who can provide the most up-to-date information based on the latest clinical evidence and individual patient needs. The scientific community remains engaged in resolving these debates through continued rigorous research.
Does Whole-Body PBM Improve Exercise Performance or Recovery?
Whole-body photobiomodulation (PBM) has been studied for its potential to enhance exercise performance and recovery, but current evidence suggests it does not provide significant benefits in these areas. A systematic review published in 2025 specifically evaluated the efficacy of whole-body PBM for exercise performance and recovery, comparing its findings to the more established effects of localized PBM. The review included five studies with a total of 105 physically active participants, representing both sexes and engaging in various exercise modalities [https://pubmed.ncbi.nlm.nih.gov/39883205/].
The main conclusion from this review was clear: none of the five studies reported any benefit of whole-body PBM on biomarkers of fatigue and exercise performance. This means that when participants were exposed to red and near-infrared light across their entire body, there was no measurable improvement in how well they performed during exercise or how quickly their bodies recovered afterward, based on objective indicators. This finding contrasts with some of the reported benefits of localized PBM, where specific areas of the body are treated, which has shown more promise in improving muscle recovery and reducing soreness.
Whole-Body PBM and Sleep Quality
While whole-body PBM did not demonstrate benefits for exercise performance or recovery, the systematic review did highlight a different potential advantage: improved sleep quality. Two out of the five studies included in the review reported better sleep quality among participants who used whole-body PBM. These improvements were determined by both subjective questionnaires, where participants reported feeling better rested, and objective measures from commercial sleep trackers. Additionally, these studies observed higher serum melatonin levels, which is a hormone crucial for regulating sleep-wake cycles, and lower nocturnal heart rates in participants receiving whole-body PBM [https://pubmed.ncbi.nlm.nih.gov/39883205/].
The observation that whole-body PBM may improve sleep quality is an interesting finding, even if it doesn't directly relate to exercise performance or recovery. Better sleep is fundamental for overall health and can indirectly support physical well-being. This suggests that while whole-body PBM might not be a direct ergogenic aid for athletes, it could still offer general wellness benefits. The review's findings on Whole-body PBM for exercise performance and recovery provide a clear distinction between the potential effects on sleep versus athletic metrics. This indicates that the light may be influencing systemic physiological processes that contribute to relaxation and sleep regulation, rather than directly enhancing muscle function or repair mechanisms related to exercise.
Discrepancies with Localized PBM
The systematic review pointed out that further research is necessary to resolve discrepancies between the findings for whole-body PBM and the benefits observed in localized PBM studies. Localized PBM, where specific muscles or joints are treated, has shown more promising results in areas like reducing muscle soreness, accelerating recovery from exercise-induced muscle damage, and improving muscle function. This difference might be due to several factors, including the dosage of light reaching specific tissues, the penetration depth of light, or the specific physiological responses triggered by localized versus systemic exposure.
"Whole-body PBM may improve sleep quality but shows no evidence of benefits for exercise recovery or performance. Further research is necessary to resolve discrepancies with the benefits observed in localized PBM studies," stated Mario Álvarez-Martínez et al., in Lasers Med Sci. 2025 [https://pubmed.ncbi.nlm.nih.gov/39883205/]. This quote encapsulates the current understanding: while the general wellness benefit of improved sleep is noted, the direct athletic advantages are not yet supported by evidence for whole-body PBM. This highlights the importance of distinguishing between different application methods and their respective outcomes. Future research will need to explore optimal parameters for whole-body PBM, or perhaps confirm that localized application is indeed more effective for specific aspects of exercise performance and recovery. For now, individuals looking to enhance athletic performance or speed up muscle recovery through PBM might find localized treatments to be more evidence-backed than whole-body approaches.
What Are the Safety Considerations for PBM?
The safety profile of photobiomodulation (PBM) has been a consistent point of positive findings across various studies. The incidence of adverse events with PBM has been consistently low, reinforcing its safety for therapeutic applications. This is a critical factor when considering any medical or wellness treatment, particularly for conditions that require ongoing management or for individuals with sensitive health profiles. The non-invasive nature of PBM contributes significantly to its favorable safety record, as it avoids the risks associated with surgical procedures or systemic medications.
A systematic review focusing on PBM in chronic pain, which included fourteen studies, explicitly stated that the incidence of adverse events was low, thus reinforcing the method's safety [https://pubmed.ncbi.nlm.nih.gov/41710353/]. This finding is consistent with other research on PBM, such as the 2002 study on fibromyalgia patients, which also reported no side effects from low-power laser therapy [https://pubmed.ncbi.nlm.nih.gov/11845369/]. These consistent reports across different conditions and study periods suggest a robust safety profile for PBM when used appropriately.
Factors Influencing Safety
While PBM is generally considered safe, understanding the factors that contribute to this safety, as well as potential minor considerations, is important. The light sources used in PBM, typically red and near-infrared lasers or LEDs, operate within specific wavelengths and power densities designed to be therapeutic without causing tissue damage. Unlike high-power lasers used in surgery, PBM devices use low-level light that does not generate significant heat, thus minimizing the risk of burns or discomfort. The controlled application of light, adhering to established protocols for dosage and exposure time, is key to maintaining this safety.
However, the systematic review on chronic pain also noted that the heterogeneity of technical parameters across studies can compromise the standardization of results. This means that while safety is consistent, the exact optimal settings (like wavelength, power, duration, and frequency of treatment) for maximizing efficacy might still vary and require further research. This variability, while not directly impacting safety when treatments are within established safe ranges, can make it challenging to compare the precise effectiveness of different PBM approaches for specific conditions. Despite these differences in parameters, the overall safety trend remains strong.
Specific Safety Measures and Precautions
When undergoing PBM, certain precautions are typically observed to ensure safety. Eye protection is commonly worn, especially when treating areas near the face, to prevent direct exposure of the eyes to the intense light, although the wavelengths used in PBM are generally considered safe for skin exposure. For individuals with certain medical conditions, such as pregnancy, or those taking photosensitizing medications, consultation with a healthcare provider is always recommended before starting PBM. However, these are general precautions for many light-based therapies and do not indicate a high inherent risk with PBM itself.
The lack of significant adverse events reported in major systematic reviews and clinical trials is a strong indicator of PBM's safety. This includes studies on diverse populations, from those with chronic pain conditions like fibromyalgia and peripheral neuropathies to physically active individuals exploring exercise recovery. The consistent reporting of low or no adverse events across these varied applications underscores PBM's potential as a well-tolerated therapeutic option. As PBM continues to gain recognition and acceptance, its well-established safety profile will remain a cornerstone of its appeal for both patients and clinicians seeking effective, non-invasive treatments.
Frequently Asked Questions
Is photobiomodulation (PBM) a new therapy?
No, photobiomodulation (PBM), often known as red light therapy or low-level laser therapy (LLLT), is not a new therapy. Its scientific foundations and applications have been studied for decades. For example, a single-blind, placebo-controlled trial investigating the efficacy of low-power laser therapy in fibromyalgia patients was published as early as 2002 [https://pubmed.ncbi.nlm.nih.gov/11845369/]. This long history of research shows that the principles and therapeutic potential of using light for healing have been explored and refined over many years.
Can PBM be used for conditions other than pain?
Yes, PBM is being explored for a range of conditions beyond just pain management. For instance, PBM is a controversial approach for managing dry age-related macular degeneration (AMD), aiming to influence mitochondrial activity in the retina [https://pubmed.ncbi.nlm.nih.gov/39148091/]. While its efficacy for AMD is still debated, this shows its application in vision care. Additionally, whole-body PBM has been found to potentially improve sleep quality, with two out of five studies reporting higher serum melatonin and lower nocturnal heart rates in physically active participants [https://pubmed.ncbi.nlm.nih.gov/39883205/].
Are there any side effects of PBM?
The incidence of adverse events with PBM has been consistently low across various studies, reinforcing its safety profile. A systematic review on PBM for chronic pain, which included fourteen studies, specifically noted a low incidence of adverse events, reinforcing the method's safety [https://pubmed.ncbi.nlm.nih.gov/41710353/]. Similarly, a 2002 study on low-power laser therapy for fibromyalgia reported no side effects [https://pubmed.ncbi.nlm.nih.gov/11845369/]. This suggests that PBM is generally well-tolerated and carries minimal risks when used appropriately.
How does PBM compare to traditional treatments?
PBM offers a non-invasive alternative or complementary approach to traditional treatments, often with fewer side effects. For chronic pain, PBM has shown significant pain reduction, particularly in fibromyalgia and neuropathy, and in some studies, functional gains and improved quality of life were observed [https://pubmed.ncbi.nlm.nih.gov/41710353/]. Unlike many pharmacological treatments, PBM does not involve medication and its associated systemic side effects. However, the effectiveness of PBM can vary depending on the condition and specific protocols used, and it is often used as part of a broader treatment plan.
Where can I find more information on clinical trials for PBM?
You can find more information on clinical trials for PBM by searching public databases like ClinicalTrials.gov. For example, a study titled "Low-level Laser Therapy in Patients With Chronic Fibromyalgia" is registered under the identifier NCT02948634 [https://clinicaltrials.gov/study/NCT02948634]. These databases provide details on ongoing and completed studies, including their objectives, eligibility criteria, and results when available. They are valuable resources for staying informed about the latest research and understanding the scientific basis of PBM applications.
Related Reading
- Red Light Therapy for Athletes: Performance and Recovery Science
- Red Light Therapy for Muscle Recovery After Workouts
- What the Research Says About Red Light Therapy for Fibromyalgia
- How Often Should You Do Red Light Therapy?
- Red Light Therapy Certification for Practitioners
— The Red Light Finder Team